Materials for binding per- and polyfluoroalkyl substances (PFAS) are disclosed. A fluidic device comprising the materials for detection and quantification of PFAS in a sample is disclosed. The fluidic device may be configured for multiplexed analyses. Also disclosed are methods for sorbing and remediating PFAS in a sample. The sample may be groundwater containing, or suspected of containing, one or more PFAS.

Decontamination compositions useful to decontaminate potentially toxic materials, such as PAH and others, present on clothing comprise an aqueous solution of a water soluble cerium salt or a dispersion of cerium oxide in water. The decontamination composition may optionally include at least one of an oxidizer, a surfactant, a co-solvent, a chelating agent, and a polymer. Methods of decontaminating clothing involve applying the decontamination composition to the clothing.

Decontamination compositions useful to decontaminate potentially toxic materials, such as PAH and others, present on clothing comprise an aqueous solution of a water soluble cerium salt or a dispersion of cerium oxide in water. The decontamination composition may optionally include at least one of an oxidizer, a surfactant, a co-solvent, a chelating agent, and a polymer. Methods of decontaminating clothing involve applying the decontamination composition to the clothing.

A compact system for treating pharmaceutical waste at a location at which the pharmaceutical waste is disposed includes a housing having a door. The housing contains a waste influent tank configured to hold and discharge a fluid comprising pharmaceutical waste; a first container configured to hold and discharge hydrogen peroxide utilized in a chemical reaction to treat the pharmaceutical waste; a second container configured to hold and discharge aqueous iron solution utilized in the chemical reaction to treat the pharmaceutical waste; and a neutralizer tank in which the chemical reaction is carried out. The door of the housing is configured to move between an open position and a closed position to allow or deny access to an interior of the housing.

A compact system for treating pharmaceutical waste at a location at which the pharmaceutical waste is disposed includes a housing having a door. The housing contains a waste influent tank configured to hold and discharge a fluid comprising pharmaceutical waste; a first container configured to hold and discharge hydrogen peroxide utilized in a chemical reaction to treat the pharmaceutical waste; a second container configured to hold and discharge aqueous iron solution utilized in the chemical reaction to treat the pharmaceutical waste; and a neutralizer tank in which the chemical reaction is carried out. The door of the housing is configured to move between an open position and a closed position to allow or deny access to an interior of the housing.

A composition that can decontaminate opioids on surfaces or objects, and in particular decontaminate fentanyls on surfaces using an opioid-active reagent and an opioid-effective solubilizing agent, which is a mixture of an alkyl dimethylamine oxide surfactant, an alkyl dimethylamine oxide surfactant, a C.sub.8-18 alkyl polyethylene glycol sorbitan fatty ester surfactant, and a C.sub.12-14 secondary alcohol ethoxylate surfactant. Preferably, the opioid-active reagent is chlorine dioxide. Additionally, methods for decontaminating opioids on surfaces using this composition.

A composition that can decontaminate opioids on surfaces or objects, and in particular decontaminate fentanyls on surfaces using an opioid-active reagent and an opioid-effective solubilizing agent, which is a mixture of an alkyl dimethylamine oxide surfactant, an alkyl dimethylamine oxide surfactant, a C.sub.8-18 alkyl polyethylene glycol sorbitan fatty ester surfactant, and a C.sub.12-14 secondary alcohol ethoxylate surfactant. Preferably, the opioid-active reagent is chlorine dioxide. Additionally, methods for decontaminating opioids on surfaces using this composition.

In one aspect, a composition for decomposing pharmaceutically active agents comprises an oxidizer comprising a permanganate, and an isocyanurate; and an immobilizer. In another aspect, a composition comprises up to 50 wt. % of an oxidizer comprising potassium permanganate and sodium dichloroisocyanurate dehydrate, wherein the wt. % is based on a total weight of the composition.

In one aspect, a composition for decomposing pharmaceutically active agents comprises an oxidizer comprising a permanganate, and an isocyanurate; and an immobilizer. In another aspect, a composition comprises up to 50 wt. % of an oxidizer comprising potassium permanganate and sodium dichloroisocyanurate dehydrate, wherein the wt. % is based on a total weight of the composition.

The present invention is for an improved vertical flow reactor utility that makes the technology more attractive for industrial development. The various embodiments of the invention improve various aspects of a vertical flow reactor utility. For example, in accordance with an embodiment of the invention, the design of the reactor is improved. Other embodiments provide improved systems and methods for, for example, insertion of oxygen, electrical production, and/or reactor geometry. These one or more various embodiments of the present invention lowers costs to construct, install, and/or operate a vertical flow reactor by improving economy of construction and/or operation of VFR systems.